scispace - formally typeset
Search or ask a question
Author

Joyita Banerjee

Bio: Joyita Banerjee is an academic researcher from Symbiosis International University. The author has contributed to research in topics: Medicine & Type 2 diabetes. The author has an hindex of 6, co-authored 13 publications receiving 171 citations.

Papers
More filters
01 Jan 2011
TL;DR: In this paper, the synthesis of silver nanoparticles was carried out using Syzygium cumini seed extract as reducing agent and the synthesized nanoparticles were characterized with Scanning electron microscopy (SEM), Energy dispersive X ray analysis (EDX), X-ray Diffraction (XRD), and Fourier transform Infrared Spectroscopy (FTIR).
Abstract: The environmental friendly synthesis of nanoparticles process is a revolutionary step in the field of nanotechnology. In this study, the biosynthesis of silver nanoparticles was carried out using Syzygium cumini seed extract as reducing agent. UV–visible spectroscopy was used for quantification of silver nanoparticle synthesis. The synthesized silver nanoparticles were characterized with Scanning electron microscopy (SEM), Energy dispersive X ray analysis (EDX), X-ray Diffraction (XRD) and Fourier transform Infrared Spectroscopy (FTIR). The in vitro antioxidant properties of the biosynthesized silver nanoparticles have been evaluated and these nanoparticles were found to have higher antioxidant capacity compared to the seed extract and thus can be used as potential radical scavenger against deleterious damages caused by the free radicals.

84 citations

Journal ArticleDOI
TL;DR: The potential miRNAs and miRNA signatures involved in the β cell activities and diabetes associated macrovascular and microvascular complications are summarized.

40 citations

Journal ArticleDOI
TL;DR: Sufficient 25(OH)D concentration may lower the risk of development of IR and T2DM in middle-aged control and diabetic participants.

23 citations

Journal ArticleDOI
TL;DR: In this review an attempt has been made to generate current metagenomic view on cancer microbiota, which has been found to be linked to various types of cancers, thus, contributing significantly in understanding the disease at molecular level.

21 citations

Journal ArticleDOI
TL;DR: The association of ESR and fibrinogen with glycemic markers and BP in diabetes supporting the value of emerging marker’s for early prediction of T2DM and hypertension.
Abstract: Altered blood viscosity (BV) may affect blood pressure (BP) and develops further complications in diabetes. A case-control study was performed to examine the relationship of erythrocyte sedimentation rate (ESR), hematocrit, fibrinogen, and BV with glycemic markers and BP in middle-aged normotensive and hypertensive type 2 diabetic patients and healthy controls. A total of 145 participants between age group 30–50 years divided into three groups; controls (n = 60), type 2 diabetes mellitus (T2DM, n = 55), and T2DM with hypertension (T2DM + HTN, n = 30). ESR and hematocrit were determined by Wintrobe’s method. Plasma fibrinogen was measured using Lempert method and BV calculated using Merill’s formula. T2DM and T2DM + HTN patients had higher fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), ESR, and fibrinogencompared to controls. In both male and female SBP, DBP, MAP, FPG, and HbA1c were significantly higher in T2DM and T2DM + HTN groups, compared to controls. Further, linear regression analysis revealed a positive association of ESR and fibrinogen with SBP, DBP, MAP, FPG, HbA1c, and positive diabetic status in all participants. Also, in the same analysis, BV showed a positive association with SBP, DBP, and MAP. The association of ESR and fibrinogenwith glycemic markers and BP in diabetes supporting the value of emerging marker’s for early prediction of T2DM and hypertension.

20 citations


Cited by
More filters
Journal Article
TL;DR: A diagnosis of gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes) or chemical-induced diabetes (such as in the treatment of HIV/AIDS or after organ transplantation)
Abstract: 1. Type 1 diabetes (due to b-cell destruction, usually leading to absolute insulin deficiency) 2. Type 2 diabetes (due to a progressive insulin secretory defect on the background of insulin resistance) 3. Gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes) 4. Specific types of diabetes due to other causes, e.g., monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset diabetes of the young [MODY]), diseases of the exocrine pancreas (such as cystic fibrosis), and drugor chemical-induced diabetes (such as in the treatment of HIV/AIDS or after organ transplantation)

2,339 citations

Journal ArticleDOI
TL;DR: The methods of making nanoparticles using plant extracts are reviewed, methods of particle characterization are reviewed and potential applications of the particles in medicine are discussed.

1,706 citations

Journal ArticleDOI
TL;DR: Diabetes and hypertension as comorbidities are discussed and some vascular mechanisms that predispose to both conditions are highlighted, focusing on advanced glycation end products, oxidative stress, inflammation, the immune system, and microRNAs.

771 citations

Journal ArticleDOI
TL;DR: The use of plant biomass or extracts for the biosynthesis of novel metal nanoparticles (silver, gold, platinum, and palladium) would be more significant if the nanoparticles are synthesized extracellularly and in a controlled manner according to their dispersity of shape and size as discussed by the authors.
Abstract: In recent years, nanobiotechnology has emerged as an elementary division of modern science and a noval epoch in the fields of material science and is receiving global attention due to its ample applications. Various physical, chemical, and biological methods have been employed to synthesize nanomaterials. Biological systems such as bacteria, fungi, actinomycetes, yeasts, viruses, and plants have been reported to synthesize various metal and metal oxide nanoparticles. Among these, biosynthesis of nanoparticles from plants seems to be a very effective method in developing a rapid, clean, nontoxic, and eco-friendly technology. The use of plant biomass or extracts for the biosynthesis of novel metal nanoparticles (silver, gold, platinum, and palladium) would be more significant if the nanoparticles are synthesized extracellularly and in a controlled manner according to their dispersity of shape and size. Owing to the rich biodiversity of plants, their potential use toward the synthesis of these nobel metal na...

643 citations

Journal ArticleDOI
TL;DR: In this paper, the authors describe the synthesis of gold nanoparticles (Au NPs) using seed aqueous extract of Abelmoschus esculentus and its antifungal activity.

368 citations